AlphAIAlphAI — Financial news for AI agents
investing.comSEP 212 min read$DAVA

Endava stock tumbles 10% on CFO leave, accounting probe

Endava (NYSE:DAVA) shares dropped 10% after-hours Monday as CFO Mark Thurston was placed on leave due to an accounting investigation. The probe, led by independent counsel, focuses on customer and supplier agreements. Conor McShane of AlixPartners LLP is interim CFO. The company plans to release Q4 and full-year 2026 results by November 2, 2026.

Original reporting
investing.com
Published Sep 21, 2026, 9:11 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 21, 2026, 9:19 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefCorporate actions
Primary signal
$DAVA
Bearish
high confidence
Mentioned
$DAVA
Relevance
7/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$DAVABearishHigh
01

Why it matters

The news introduces new governance risk, likely prompting short‑term selling and heightened volatility.

02

Market read

The announcement is a primary disclosure with immediate price impact, making it a high‑value trading signal.

03

What to watch

Potential hidden liabilities or client contract adjustments not yet disclosed.

Relevance 7/10Novelty 8/10Timing: after‑hours Monday

Background

Endava announced its CFO is on administrative leave pending an accounting investigation, causing a 10% share decline.

Company-level read

Ticker impact

$DAVABearishHigh confidence
Context

CFO placed on administrative leave amid accounting probe, shares fell 10% in after‑hours trading.

Expected impact

Further downside pressure expected if investigation expands; short positions may be justified.

Evidence & confidence

A 10% move on a mid‑cap with no prior warning suggests strong market reaction to governance concerns.

Market effects

Sector

Raises scrutiny on other technology services firms and may prompt broader risk reassessment.

Regional

Potential modest impact on European tech stocks where Endava has operations.

Global

Highlights governance risk in AI‑focused service providers, relevant to global investors.

Counterpoint

What could challenge this read

If the probe yields no material findings, the stock could rebound quickly.

Key entities

  • Company
    Endava plc

    Technology services provider listed on NYSE.

  • Executive
    Mark Thurston

    Chief Financial Officer placed on leave.

Read at source← All news

Related articles

JUN 27
$DAVAMed

Here is Why Endava (DAVA) is One of the Underperforming Tech Stocks to Buy According to Analysts

Endava (NYSE:DAVA) reported FQ3 2026 revenue of £178.5 million, down 8.4% year over year, citing uneven demand and longer deal cycles. The company recorded a £364.6 million goodwill impairment and related tax charges, resulting in a diluted loss per share of £7.55. For FQ4, it expects revenue of £181.0–£185.0 million and adjusted diluted EPS of £0.09–£0.13.

finance.yahoo.com4 min
SEP 21
$HEMed

HAWAIIAN ELECTRIC INDUSTRIES INC (HE): Other Events

HAWAIIAN ELECTRIC INDUSTRIES INC (HE) filed an SEC Form 8-K — Other Events. Exhibit 99 NEWS RELEASE September 21, 2026 Contact: Mateo Garcia Telephone: (808) 543-7300 Director, Investor Relations E-mail: ir@hei.com HEI BEGINS MONETIZING ASB SHARES, ENABLING ADVANCE FUNDING OF MAUI WILDFIRE SETTLEMENT HONOLULU - On September 16, 2026, Hawaiian Electric In

SEC EDGAR 8-K1 min
SEP 21
$WEAVMedAI 8/10

Weave Communications, Inc. (WEAV): Other Events

Weave Communications, Inc. (WEAV) filed an SEC Form 8-K — Other Events. Item 8.01. Other Events. As previously disclosed, on August 18, 2026, Weave Communications, Inc. (the “Company”) entered into an Agreement and Plan of Merger (the “Merger Agreement”) with Willow Parent, LLC (“Parent”) and Willow Merger Sub, Inc. (“Merger Sub”). Parent and Merger

SEC EDGAR 8-K1 min
SEP 21
$NAMSMedAI 8/10

NewAmsterdam Pharma Co N.V. (NAMS): Other Events

NewAmsterdam Pharma Co N.V. (NAMS) filed an SEC Form 8-K — Other Events. Item 8.01 Other Events. On September 21, 2026, NewAmsterdam Pharma Company N.V. (the “Company”) along with its partner Menarini Group (“Menarini”) announced that the European Commission (“EC”) has granted marketing authorization for Ubeslo ® (obicetrapib 10 mg monotherapy) and Ev

SEC EDGAR 8-K2 min
SEP 21
$ISBAMed

ISABELLA BANK CORP (ISBA): Other Events

ISABELLA BANK CORP (ISBA) filed an SEC Form 8-K — Other Events. Item 8.01. Other Events As previously announced, on June 11, 2026, Isabella Bank Corporation, a Michigan corporation (“Isabella”), 401 Merger Sub, Inc., a Michigan corporation and a wholly owned subsidiary of Isabella (“Merger Sub”), and Grand River Commerce, Inc., a Michigan cor

SEC EDGAR 8-K2 min